Senior Management

Jeffrey B. Davis, Chief Executive Officer

• President, SCO Financial Group LLC.
• Senior Vice President and Chief Financial Officer of a healthcare technology company.
• Vice President, Corporate Finance, at Deutsche Morgan Grenfell.
• Senior marketing and product management positions at AT&T Bell Laboratories.
• Marketing and Product Manager at Philips Medical Systems North America.
• MBA, The Wharton School, University of Pennsylvania.
• BS Biomedical Engineering, Boston University.

Esteban Cvitkovic, M.D., Vice Chairman, Senior Director, Clinical Oncology R&D

• Co-founder of OncoEthix
• Founder and CEO of CAC Oncology
• 30 years experience in oncology therapeutics.
• Had a fundamental role in the registration strategy and post-registration development of cisplatin and oxaliplatin
• Positions at Memorial Sloan Kettering Cancer Center (NY), Columbia Presbyterian (NY), Hospital St. Louis (Paris), Instituto Mario Negri (Milan) and Institut Gustave Roussy (Villejuif)

Agamemnon Epenetos, Ph.D., FRCP, Chief Scientific Officer – Europe

• Chairman of Trojantec Ltd, Lifeline Biotech, and Alexis Biotech.
• Founder, President and CEO of Somanta Pharmaceuticals, Inc.
• Founder, Chairman , R&D director and CSO of Antisoma plc.
• Founder of Lipoxen plc.
• Oncology and research positions at St Bartholomews Hospital (London, UK) and Imperial College London.
• Over 30 years experience in oncology therapeutics.

David P. Nowotnik, Ph.D., Senior Vice President Research and Development

• Senior Director, Product Development, Guilford Pharmaceuticals, Inc.
• Group Leader, Bristol-Myers Squibb.
• Section Leader, Amersham International.
• Research Chemist, Tate and Lyle and Aspro-Nicholas.
• PhD, Organic Chemistry, University of London.

Stephen B. Thompson, Vice President and CFO

• Controller and Administration Manager, API.
• Controller, Robert E. Woolley, Inc., a hotel real estate company.
• Controller, OKC Limited Partnership, an oil and gas company.
• Accounting and finance, Santa Fe International Corporation.

Phillip Wise, Vice President Business Development and Strategy

• VP, Commercial and Business Development and Chief Financial Officer, Enhance Pharmaceuticals.
• VP, Commercial and Business Development, Ardent Pharmaceuticals.
• Director of Managed Care Marketing & Director of New Product Planning, Glaxo Wellcome.
• MBA, University of Virginia.
• BS, Industrial and Systems Engineering, Georgia Institute of Technology.